News Releases
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
- Feb 28, 2020Specialty Finance Portfolio Performance Highlights Strong Year, Underscored by Enteris BioPharma Acquisition and NASDAQ Uplisting
SWK Holdings Corporation (Nasdaq: SWKH), a life sciences focused specialty finance company catering to small- and mid-sized commercial-stage companies, today provided an update on the progress and...
- Feb 10, 2020Accomplished Biopharmaceutical and Drug Development Executive to Lead the Expansion of Enteris' External and Internal Development Programs
Enteris BioPharma, Inc., a biotechnology company developing innovative drug products built around its proprietary delivery technologies and a wholly-owned subsidiary of SWK Holdings Corporation...
- Jan 27, 2020Enteris recognized for enhancing positive image of small businesses and service to customers
Enteris BioPharma, Inc., a biotechnology company developing innovative drug products built around its proprietary delivery technologies and a wholly-owned subsidiary of SWK Holdings Corporation...
- Jan 23, 2020Trading begins today, January 23, 2020, under the ticker symbol "SWKH"
SWK Holdings Corporation (Nasdaq: SWKH), a life science focused specialty finance company, today announced that its shares of common stock will begin trading on the Nasdaq Capital Market beginning...
- Jan 21, 2020Trading to begin on January 23, 2020
SWK Holdings Corporation (SWKH.OB) ("SWK" or the "Company"), a life science focused specialty finance company, today announced that its shares of common stock have been approved for listing on the...